Related Experiment Video
Updated: Jun 11, 2026
10:15
Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
Published on: May 9, 2025
Macrophage cell therapy in renal disease
1MRC Centre for Inflammation Research, University of Edinburgh, Little France Crescent, Edinburgh, United Kingdom.
Seminars in Nephrology
|July 13, 2010
Summary
Macrophage cell therapy shows promise for treating kidney disease by reducing inflammation and fibrosis. This approach involves modifying and injecting macrophages to repair renal tissue, improving kidney function and reducing proteinuria.
Area of Science:
- Nephrology
- Immunology
- Regenerative Medicine
Background:
- Macrophages are key players in kidney injury, inflammation, and repair processes.
- Macrophage accumulation is a hallmark of many renal diseases, contributing to tissue damage.
- However, macrophages also possess reparative functions crucial for resolving kidney disease.
Purpose of the Study:
- To investigate the therapeutic potential of ex vivo-stimulated macrophages in renal disease.
- To evaluate the efficacy of macrophage cell therapy in reducing renal inflammation and fibrosis.
- To assess the impact of this therapy on renal function and proteinuria.
Main Methods:
- Macrophages were transduced or stimulated ex vivo.
- These modified macrophages were injected after disease initiation.
- Their localization to sites of renal inflammation and therapeutic effects were analyzed.
Main Results:
- Injected macrophages preferentially localized to sites of renal inflammation.
- Macrophage cell therapy led to reduced inflammation and fibrosis in the kidney.
- Improved renal function and attenuation of proteinuria were observed.
Conclusions:
- Ex vivo-manipulated macrophage therapy is a viable strategy for treating renal disease.
- This approach offers a potential platform for translational applications in human kidney disorders.
- Macrophage cell therapy demonstrates significant potential for promoting renal repair and recovery.
